IP Library › Granted Patent US 10,823,982
Granted Patent B2
US 10,823,982 · App. 16/155,097 · Granted Nov 3, 2020

Myopia treatment device

Inventors: Kazuo Tsubota (Funabashi, JP); Kazuno Negishi (Meguro-ku, JP); Hidemasa Torii (Yokohama, JP); Toshihide Kurihara (Shibuya-ku, JP)
Assignee: TSUBOTA LABORATORY, INC.
G02C7/104A61F2/1602G02B5/208G02B5/22A61F2002/1696A61N2005/0648A61N2005/0663A61N2005/0667B60R1/083G02B1/11G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,823,982
App. No.
16/155,097
Granted
Nov 3, 2020
Kind
B2
Abstract

The purpose of the present invention is to provide a myopia treatment device. A myopia treatment device of the present invention comprises a light transmission part selected from a group consisting of an eyesight correcting tool, an eye protection tool, a face protection tool, a sunshade, a display device, a window, a wall, a light source covering, and a coating material. The light transmission part of the device transmits violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treats myopia. Or, the myopia treatment device comprises a light emission part selected from a group consisting of lighting equipment, a display device, and a light irradiation device. The light emission part of the device emits violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treats myopia.

Claims (27)

1. A myopia treatment device comprising:

a light transmission part selected from a group consisting of an eyesight correcting tool, an eye protection tool, a face protection tool, a sunshade, a display device, a window, a wall, a light source covering, and a coating material, wherein:

the light transmission part of the device transmits violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treats myopia; and

the violet light having a wavelength within the range of 360 nm to 400 nm inclusive and transmitted through the light transmission part reaches the eye at an irradiance of 1.0 mW/cm 2 or less.

2. The myopia treatment device according to claim 1 , wherein

the light transmission part does not transmit light having a wavelength of 315 nm or less.

3. The myopia treatment device according to claim 2 , wherein

a transmission rate of the light having a wavelength of 315 nm or less is 1% or less.

4. The myopia treatment device according to claim 1 , wherein

the light transmission part does not transmit light having a wavelength less than 350 nm.

5. The myopia treatment device according to claim 1 , wherein

the light transmission part further transmits light having a wavelength greater than 400 nm.

6. The myopia treatment device according to claim 1 , wherein

the myopia treatment achieves one or two or more effects selected from shortening an axial length of the eye, lowering a refractive value (absolute value), and improving naked vision.

7. A myopia treatment device comprising:

a light emission part selected from a group consisting of lighting equipment, a display device, and a light irradiation device, wherein:

the light emission part of the device emits violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treats myopia; and

the violet light having a wavelength within the range of 360 nm to 400 nm inclusive and emitted from the light emission part reaches the eye at an irradiance of 1.0 mW/cm 2 or less.

8. The myopia treatment device according to claim 7 , wherein

the light emission part further emits light having a wavelength greater than 400 nm.

9. The myopia treatment device according to claim 7 , further comprising a light-emitting device provided with an excitation light emission part that emits excitation light having a wavelength within a range of 360 nm to 400 nm inclusive, and fluorescent substances of red, green, and blue provided so as to cover the excitation light emission part.

10. The myopia treatment device according to claim 7 , further comprising a light-emitting device provided with a light emission part that emits light having a wavelength within a range of 360 nm to 400 nm inclusive, and light emission parts of red, green, and blue.

11. A set comprising:

a first myopia treatment device provided with a light transmission part selected from a group consisting of an eyesight correcting tool, an eye protection tool, a face protection tool, a sunshade, a display device, a window, a wall, a light source covering, and a coating material, the light transmission part of the device transmitting violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treating myopia; and

a second myopia treatment device provided with a light emission part selected from a group consisting of lighting equipment, a display device, and a light irradiation device, the light emission part of the device emitting violet light having a wavelength within a range of 360 nm to 400 nm inclusive and thus treating myopia, wherein:

the violet light having a wavelength within the range of 360 nm to 400 nm inclusive and transmitted through the light transmission part reaches the eye at an irradiance of 1.0 mW/cm 2 or less; and

the violet light having a wavelength within the range of 360 nm to 400 nm inclusive and emitted from the light emission part reaches the eye at an irradiance of 1.0 mW/cm 2 or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2018
From: TSUBOTA, KAZUO; NEGISHI, KAZUNO; TORII, HIDEMASA; KURIHARA, TOSHIHIDE
To: TSUBOTA LABORATORY, INC.
Reel/Frame 047806/0970 →
Priority Claims (1)
JP 2014-115286 · Jun 3, 2014 · national
Continuity (3)
Continuation In Part 15366558 · Dec 1, 2016
Continuation In Part PCTJP2015065997 · Jun 3, 2015
Related Publication 20190129204A1 · May 2, 2019